Matthew C Cheung Selected Research

Matthew C Cheung Research Topics

Disease

21	Neoplasms (Cancer) 04/2024 - 06/2005
12	Lymphoma (Lymphomas) 01/2023 - 06/2006
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 04/2007
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 04/2007
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 02/2015
4	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 04/2007
4	Hodgkin Disease (Hodgkin's Disease) 02/2020 - 04/2010
3	COVID-19 10/2023 - 01/2022
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 04/2016
3	Multiple Myeloma 09/2021 - 03/2016
3	Acquired Immunodeficiency Syndrome (AIDS) 04/2010 - 06/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2023 - 01/2021
2	Infections 01/2023 - 01/2022
2	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2021
2	Thrombocytopenia (Thrombopenia) 10/2021 - 04/2018
2	Anemia 10/2021 - 03/2016
2	Death (Near-Death Experience) 01/2020 - 09/2015
2	Neutropenia 04/2018 - 01/2014
2	Disease Progression 03/2016 - 11/2014
2	Febrile Neutropenia 01/2014 - 12/2010
1	Heart Failure 04/2024
1	Frailty 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Thrombotic Microangiopathies 09/2021
1	Leukemia 12/2020
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 10/2020
1	Pure Red-Cell Aplasia 10/2020
1	Overweight 01/2019
1	Rubella (German Measles) 04/2018
1	Exanthema (Rash) 03/2016
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 11/2014
1	Rare Diseases (Rare Disease) 11/2014
1	Obesity 12/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2007

Drug/Important Bio-Agent (IBA)

13	Rituximab (Mabthera)FDA Link 10/2023 - 04/2007
7	Prednisone (Sone)FDA LinkGeneric 01/2023 - 10/2012
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 10/2012
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 10/2012
6	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 10/2012
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 07/2015
4	Azacitidine (5 Azacytidine)FDA Link 11/2023 - 02/2015
3	Guanosine Diphosphate (GDP)IBA 01/2023 - 07/2015
3	Gemcitabine FDA Link 01/2023 - 07/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 07/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 11/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	Bendamustine Hydrochloride FDA Link 01/2023 - 11/2021
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 07/2015
2	ibrutinibIBA 11/2021 - 01/2019
2	ibritumomab tiuxetan (Zevalin)FDA Link 04/2018 - 06/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014 - 12/2010
2	Methotrexate (Mexate)FDA LinkGeneric 09/2012 - 10/2011
1	venetoclaxIBA 11/2023
1	VaccinesIBA 01/2023
1	Heme (Haem)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	polatuzumab vedotinIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	CreatinineIBA 10/2021
1	carfilzomibIBA 09/2021
1	AlbuminsIBA 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 11/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2020
1	romidepsin (FK228)FDA Link 01/2019
1	InterferonsIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 04/2018
1	Lenalidomide (CC 5013)FDA Link 03/2016
1	Melphalan (Alkeran)FDA LinkGeneric 03/2016
1	Thalidomide (Thalomid)FDA Link 03/2016
1	eculizumab FDA Link 11/2014
1	R-CHOP protocolIBA 06/2014
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2014
1	Dacarbazine (DIC)FDA LinkGeneric 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2010
1	pipoxolan (BR 18)IBA 12/2009

Therapy/Procedure

14	Therapeutics 01/2023 - 06/2005
13	Drug Therapy (Chemotherapy) 01/2022 - 06/2005
4	Immunotherapy 11/2020 - 04/2018
4	Radiotherapy 01/2020 - 10/2011
3	Highly Active Antiretroviral Therapy (HAART) 04/2010 - 06/2005
2	Ambulatory Care (Outpatient Care) 01/2023 - 01/2021
2	Transplantation 02/2020 - 10/2019
2	Terminal Care (Care, Terminal) 01/2020 - 09/2015
2	Palliative Care (Palliative Therapy) 01/2020 - 09/2015
1	Immunomodulation 04/2024
1	Induction Chemotherapy 11/2023
1	Operative Surgical Procedures 01/2022
1	Neoadjuvant Therapy 01/2022
1	Plasma Exchange 09/2021
1	Precision Medicine 01/2021
1	Drug Tapering 01/2019
1	Stem Cell Transplantation 07/2015
1	Treatment Delay 02/2015
1	Combined Modality Therapy 09/2012